Technical Articles

IL-1β (Interleukin-1β) is one of the most potent pro-inflammatory cytokines in the body and is regarded as the "initiating factor" of inflammatory responses. Its production requires a precise and complex activation mechanism.

In the field of tumor immunology, the complex regulatory network of inflammation and immune response has always been a research hotspot. Interleukin-1 β (IL-1 β), as a key pro-inflammatory cytokine, plays a "double agent" role in the interaction between the immune system and the tumor microenvironment. On the one hand, IL-1 β activates anti-tumor immune mechanisms by inducing acute inflammatory responses, directly or indirectly killing cancer cells; On the other hand, under specific conditions, it may accelerate tumor progression by promoting angiogenesis, tumor cell proliferation, and other pathways. The duality of this function makes it a highly controversial and promising target in tumor immunotherapy research.